Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody

Abstract Immunoglobulin G (IgG) antibodies contain a complex N-glycan embedded in the hydrophobic pocket between its heavy chain protomers. This glycan contributes to the structural organization of the Fc domain and determines its specificity for Fcγ receptors, thereby dictating distinct cellular re...

Full description

Bibliographic Details
Main Authors: Aaron Gupta, Kevin S. Kao, Rachel Yamin, Deena A. Oren, Yehuda Goldgur, Jonathan Du, Pete Lollar, Eric J. Sundberg, Jeffrey V. Ravetch
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-38453-1
_version_ 1797822713083985920
author Aaron Gupta
Kevin S. Kao
Rachel Yamin
Deena A. Oren
Yehuda Goldgur
Jonathan Du
Pete Lollar
Eric J. Sundberg
Jeffrey V. Ravetch
author_facet Aaron Gupta
Kevin S. Kao
Rachel Yamin
Deena A. Oren
Yehuda Goldgur
Jonathan Du
Pete Lollar
Eric J. Sundberg
Jeffrey V. Ravetch
author_sort Aaron Gupta
collection DOAJ
description Abstract Immunoglobulin G (IgG) antibodies contain a complex N-glycan embedded in the hydrophobic pocket between its heavy chain protomers. This glycan contributes to the structural organization of the Fc domain and determines its specificity for Fcγ receptors, thereby dictating distinct cellular responses. The variable construction of this glycan structure leads to highly-related, but non-equivalent glycoproteins known as glycoforms. We previously reported synthetic nanobodies that distinguish IgG glycoforms. Here, we present the structure of one such nanobody, X0, in complex with the Fc fragment of afucosylated IgG1. Upon binding, the elongated CDR3 loop of X0 undergoes a conformational shift to access the buried N-glycan and acts as a ‘glycan sensor’, forming hydrogen bonds with the afucosylated IgG N-glycan that would otherwise be sterically hindered by the presence of a core fucose residue. Based on this structure, we designed X0 fusion constructs that disrupt pathogenic afucosylated IgG1-FcγRIIIa interactions and rescue mice in a model of dengue virus infection.
first_indexed 2024-03-13T10:13:11Z
format Article
id doaj.art-0c91ddacfecf4f7fb89461122325693e
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-13T10:13:11Z
publishDate 2023-05-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-0c91ddacfecf4f7fb89461122325693e2023-05-21T11:20:58ZengNature PortfolioNature Communications2041-17232023-05-0114111110.1038/s41467-023-38453-1Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobodyAaron Gupta0Kevin S. Kao1Rachel Yamin2Deena A. Oren3Yehuda Goldgur4Jonathan Du5Pete Lollar6Eric J. Sundberg7Jeffrey V. Ravetch8Laboratory of Molecular Genetics & Immunology, The Rockefeller UniversityLaboratory of Molecular Genetics & Immunology, The Rockefeller UniversityLaboratory of Molecular Genetics & Immunology, The Rockefeller UniversityStructural Biology Resource Center, The Rockefeller UniversityStructural Biology Program, Memorial Sloan Kettering Cancer CenterDepartment of Biochemistry, Emory University School of MedicineDepartment of Pediatrics, Emory University School of MedicineDepartment of Biochemistry, Emory University School of MedicineLaboratory of Molecular Genetics & Immunology, The Rockefeller UniversityAbstract Immunoglobulin G (IgG) antibodies contain a complex N-glycan embedded in the hydrophobic pocket between its heavy chain protomers. This glycan contributes to the structural organization of the Fc domain and determines its specificity for Fcγ receptors, thereby dictating distinct cellular responses. The variable construction of this glycan structure leads to highly-related, but non-equivalent glycoproteins known as glycoforms. We previously reported synthetic nanobodies that distinguish IgG glycoforms. Here, we present the structure of one such nanobody, X0, in complex with the Fc fragment of afucosylated IgG1. Upon binding, the elongated CDR3 loop of X0 undergoes a conformational shift to access the buried N-glycan and acts as a ‘glycan sensor’, forming hydrogen bonds with the afucosylated IgG N-glycan that would otherwise be sterically hindered by the presence of a core fucose residue. Based on this structure, we designed X0 fusion constructs that disrupt pathogenic afucosylated IgG1-FcγRIIIa interactions and rescue mice in a model of dengue virus infection.https://doi.org/10.1038/s41467-023-38453-1
spellingShingle Aaron Gupta
Kevin S. Kao
Rachel Yamin
Deena A. Oren
Yehuda Goldgur
Jonathan Du
Pete Lollar
Eric J. Sundberg
Jeffrey V. Ravetch
Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
Nature Communications
title Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
title_full Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
title_fullStr Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
title_full_unstemmed Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
title_short Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
title_sort mechanism of glycoform specificity and in vivo protection by an anti afucosylated igg nanobody
url https://doi.org/10.1038/s41467-023-38453-1
work_keys_str_mv AT aarongupta mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT kevinskao mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT rachelyamin mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT deenaaoren mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT yehudagoldgur mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT jonathandu mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT petelollar mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT ericjsundberg mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody
AT jeffreyvravetch mechanismofglycoformspecificityandinvivoprotectionbyanantiafucosylatediggnanobody